APA (7th ed.) Citation

Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), & International Conference on Harmonisation. (2008). Guidance for industry: S1C(R2) dose selection for carcinogenicity studies. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research ; Center for Biologics Evaluation and Research.

Chicago Style (17th ed.) Citation

Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), and International Conference on Harmonisation. Guidance for Industry: S1C(R2) Dose Selection for Carcinogenicity Studies. Silver Spring, MD : [Rockville, Md.]: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research ; Center for Biologics Evaluation and Research, 2008.

MLA (9th ed.) Citation

Center for Drug Evaluation and Research (U.S.), et al. Guidance for Industry: S1C(R2) Dose Selection for Carcinogenicity Studies. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research ; Center for Biologics Evaluation and Research, 2008.